BXP:LSE Beximco Pharmaceuticals Limited

GBX 38.50 0.00 0
Icon

Beximco Pharmaceuticals Limited (BXP:LSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 38.50

0.00 (0.00)%

GBX 0.17B

6.97K

N/A

N/A

Icon

BXP:LSE

Beximco Pharmaceuticals Limited (GBX)
COMMON STOCK | LSE
GBX 38.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.17B

N/A

GBX 38.50

Beximco Pharmaceuticals Limited (BXP:LSE) Stock Forecast

N/A

Based on the Beximco Pharmaceuticals Limited stock forecast from 0 analysts, the average analyst target price for Beximco Pharmaceuticals Limited is not available over the next 12 months. Beximco Pharmaceuticals Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Beximco Pharmaceuticals Limited is Bullish , which is based on 12 positive signals and 2 negative signals. At the last closing, Beximco Pharmaceuticals Limited’s stock price was GBX 38.50. Beximco Pharmaceuticals Limited’s stock price has changed by +0.00% over the past week, -2.53% over the past month and +5.48% over the last year.

No recent analyst target price found for Beximco Pharmaceuticals Limited
No recent average analyst rating found for Beximco Pharmaceuticals Limited

Company Overview Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system,...Read More

19 Dhanmondi R/A, Dhaka, Bangladesh, 1205

5,500

June

GBX

UK

Adjusted Closing Price for Beximco Pharmaceuticals Limited (BXP:LSE)

Loading...

Unadjusted Closing Price for Beximco Pharmaceuticals Limited (BXP:LSE)

Loading...

Share Trading Volume for Beximco Pharmaceuticals Limited Shares

Loading...

Compare Performance of Beximco Pharmaceuticals Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BXP:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Beximco Pharmaceuticals Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HLN:LSE
Haleon PLC +2.40 (+0.71%) GBX31.12B 28.40 16.14

ETFs Containing BXP

Symbol Name BXP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Beximco Pharmaceuticals Limited (BXP:LSE) Stock

Stock Target Advisor's fundamental analysis for Beximco Pharmaceuticals Limited's stock is Bullish .

BXP:LSE stock's dividend yield is 6.53%. Our analysis grades BXP:LSE stock's dividend yield at A+. This means that BXP:LSE stock's dividend yield is above 100% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the LSE exchange. Based on this BXP:LSE may be a good dividend stock for its sector.

Unfortunately we do not have enough data on BXP:LSE's stock to indicate what its average analyst target is.

BXP:LSE stock's Price/Earning ratio is 4.81. Our analysis grades BXP:LSE stock's Price / Earning ratio at A-. This means that BXP:LSE stock's Price/Earning ratio is above 9.999999999999998% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the LSE exchange. Based on this BXP:LSE may be undervalued for its sector.

The last closing price of BXP:LSE's stock was GBX 38.50.

The most recent market capitalization for BXP:LSE is GBX 0.17B.

Unfortunately we do not have enough analyst data on BXP:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Beximco Pharmaceuticals Limited's stock.

As per our most recent records Beximco Pharmaceuticals Limited has 5,500 Employees.

Beximco Pharmaceuticals Limited's registered address is 19 Dhanmondi R/A, Dhaka, Bangladesh, 1205. You can get more information about it from Beximco Pharmaceuticals Limited's website at https://www.beximcopharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...